Prelude Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,095
Closed -$241K 1215
2025
Q4
$241K Buy
+6,095
New +$223K 0.02% 920
2024
Q2
Sell
-7,143
Closed -$217K 1221
2024
Q1
$217K Sell
7,143
-25,321
-78% -$848K 0.01% 1069
2023
Q4
$1.16M Buy
32,464
+20,738
+177% +$771K 0.1% 268
2023
Q3
$514K Buy
11,726
+3,767
+47% +$184K 0.05% 470
2023
Q2
$393K Buy
+7,959
New +$367K 0.03% 560
2023
Q1
Sell
-12,362
Closed -$549K 1181
2022
Q4
$549K Buy
12,362
+5,161
+72% +$216K 0.03% 534
2022
Q3
$282K Sell
7,201
-508
-7% -$23.2K 0.01% 896
2022
Q2
$315K Buy
+7,709
New +$365K 0.02% 1036
2022
Q1
Sell
-3,290
Closed -$229K 1823
2021
Q4
$229K Buy
3,290
+235
+8% +$17.1K 0.01% 1488
2021
Q3
$212K Sell
3,055
-1,030
-25% -$79.3K 0.01% 1333
2021
Q2
$324K Buy
+4,085
New +$297K 0.02% 1160
2020
Q1
Sell
-39
Closed -$1K 1442
2019
Q4
$1K Sell
39
-1,315
-97% -$37.4K ﹤0.01% 1843
2019
Q3
$34K Buy
1,354
+733
+118% +$20.9K ﹤0.01% 1275
2019
Q2
$19K Sell
621
-1,621
-72% -$47.3K ﹤0.01% 1291
2019
Q1
$60K Buy
2,242
+1,785
+391% +$54.2K 0.01% 1074
2018
Q4
$14K Buy
457
+235
+106% +$7.32K ﹤0.01% 1296
2018
Q3
$8K Buy
222
+14
+7% +$443 ﹤0.01% 1502
2018
Q2
$6K Sell
208
-19,930
-99% -$468K ﹤0.01% 1542
2018
Q1
$413K Buy
20,138
+1,086
+6% +$19.6K 0.04% 491
2017
Q4
$348K Buy
19,052
+4,840
+34% +$95.8K 0.03% 505
2017
Q3
$318K Buy
14,212
+365
+3% +$8.25K 0.03% 502
2017
Q2
$336K Buy
13,847
+3,233
+30% +$68.7K 0.03% 427
2017
Q1
$203K Sell
10,614
-6,528
-38% -$114K 0.02% 554
2016
Q4
$335K Buy
17,142
+15,038
+715% +$273K 0.04% 405
2016
Q3
$33K Buy
+2,104
New +$32.3K ﹤0.01% 1183
2015
Q2
Sell
-3,000
Closed -$61K 1689
2015
Q1
$61K Buy
+3,000
New +$58.1K 0.01% 1204

Other funds holding ATRC